Sentante is another step closer to treating patients with its remote endovascular robotics system after earning CE mark approval in May. “This is a defining moment for Sentante,” Sentante co-founder and CEO Edvardas Satkauskas said in a news release. “We are now positioned to move decisively into commercialization and begin delivering real impact for clinicians…
The post Sentante has a CE mark, its CEO says much more to come for endovascular robotics appeared first on Medical Design and Outsourcing.